Wegovy

Clinical News

Oral semaglutide as effective as injectable

David Rowley 29/05/2023

Ozempic/Wegovy sponsor trumpets results of Phase III clinical trial as its halts US ads A trial of an oral version of Novo Nordisk’s obesity and diabetes medication semaglutide, the active …

News

TGA approves next generation diabetes drug Mounjaro

David Rowley 19/01/2023

Will Eli Lilly’s potential blockbuster get the same social media weight-loss attention as shortage plagued Ozempic? The next generation of Type-2 diabetes drugs – and by extension weight-loss drugs – …

News

Musk plugs weight loss drug on Twitter

David Rowley 17/10/2022

Wild card billionaire puts new, trim look down to fasting and taking semaglutide prep Wegovy Mercurial South African billionaire Elon Musk has sent social media into a minor swirl again …

This web site is intended for Australian pharmacy professionals and is not a substitute for independent professional advice. Information and interactions contained in this website are for information purposes only and are not intended to be used to diagnose, treat, cure or prevent any disease. Further the accuracy, currency and completeness of the information available on this web site cannot be guaranteed. APPco Pty Ltd, its affiliates and their respective servants and agents do not accept any liability for any injury, loss or damage incurred by use of or reliance on the information made available via or through ajp.com.au whether arising from negligence or otherwise.

Oral semaglutide as effective as injectable

TGA approves next generation diabetes drug Mounjaro

Musk plugs weight loss drug on Twitter

MENU

ajp.com.au

Tags

Hi there! 👋 Looks like you’re not logged in.